Lyxumia® is first diabetes therapy of its class approved in Japan for use in combination with basal insulin
28 June 2013 | By Sanofi
Japan’s MHLW has approved the manufacturing and distribution of Lyxumia®...
List view / Grid view
28 June 2013 | By Sanofi
Japan’s MHLW has approved the manufacturing and distribution of Lyxumia®...
22 June 2013 | By Sanofi
Topline results of EDITION II consistent with EDITION I findings...
19 June 2013 | By Sanofi
Preclinical program of translational research to identify new target proteins...
18 June 2013 | By Sanofi
"an important opportunity for Sanofi to share significant data..."
5 June 2013 | By Sanofi
ORIGIN was a landmark, seven-year clinical trial...
3 June 2013 | By Sanofi
Sanofi announced topline results of two Phase 3 clinical studies...
23 May 2013 | By Sanofi
Sanofi is pleased to announce the appointment of David Loew, effective July 1st , 2013.
17 May 2013 | By Sanofi
The French ministerial mission has presented the conclusions of its report regarding the Sanofi Research site in Toulouse, France...
15 May 2013 | By Sanofi
Comprehensive SARIL-RA development program to include 2,600 patients in four Phase 3 and one open-label extension trials...
2 May 2013 | By Sanofi
A new commercial organization to better align with its business priorities...
25 April 2013 | By Sanofi
Genzyme announced positive top-line results from the TOPIC trial for AUBAGIO...
25 April 2013 | By Sanofi
More than 200 million treatments of ASAQ Winthrop have been distributed in Africa...
17 April 2013 | By Sanofi
Sanofi announced the opening of its new logistics hub in Casablanca, Morocco...
11 April 2013 | By Sanofi
A pivotal milestone in the fight against malaria...
29 March 2013 | By Sanofi
“This new production and development center is the largest investment ever made by Sanofi in Vietnam..."